2-[¹⁸F]-FDG PET for imaging brain involvement in patients with long COVID: perspective of the EANM Neuroimaging Committee

Affiliations

• ¹ Department of Nuclear Medicine and Nancyclotep Imaging Platform, CHRU Nancy, Université de Lorraine, 54000, Nancy, France.
• ² Université de Lorraine, IADI, INSERM U1254, F-54000, Nancy, France.
• ³ Department of Nuclear Medicine, Leipzig University, Leipzig, Germany.
• ⁴ Department of Radiology and Nuclear Medicine, University Medical Center Utrecht, Utrecht, The Netherlands.
• ⁵ Institute of Nuclear Medicine, University College London (UCL), London, UK.
• ⁶ Nuclear Medicine Unit, Department of Medicine - DIMED, University of Padua, Padua, Italy.
• ⁷ Department of Nuclear Medicine, Ludwig Maximilians-University of Munich, Munich, Germany.
• ⁸ Department of Radiology and Nuclear Medicine, UMC, Location VUmc, Amsterdam, The Netherlands.
• ⁹ Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
• ¹⁰ German Centre of Neurodegenerative Diseases (DZNE), Site Munich, Bonn, Germany.
• ¹¹ Nuclear Medicine Dept, Sisli Hamidiye Etfal Education and Research Hospital, University of Health Sciences, Istanbul, Turkey.
• ¹² Nuclear Medicine Department, University Hospital, Lille, France.
• ¹³ Division of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria.
• ¹⁴ Department of Radiology and Nuclear Medicine, Ghent University Hospital, Ghent, Belgium.
• ¹⁵ IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
• ¹⁶ Nuclear Medicine Unit, Department of Health Sciences, University of Genoa, Genoa, Italy.
• ¹⁷ Institut Fresnel, Nuclear Medicine Department, APHM, CNRS, Timone Hospital, CERIMED, Aix Marseille Univ, Centrale Marseille, 264 rue Saint Pierre, 13005, Marseille, France. eric.guedj@ap-hm.fr.